NCT06420947

Brief Summary

This is a parallel and randomized-controlled clinical study aimed to identify the optimized size of atomized particles of 2% lidocaine that can provide the best topical anesthesia during ATI. To determine the effect of nebulization with different sizes of atomized particles of 2% lidocaine on cough, reaction, and comfort during ATI in patients with predicted difficult airway.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 20, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

September 5, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2025

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2025

Completed
Last Updated

April 22, 2025

Status Verified

September 1, 2024

Enrollment Period

5 months

First QC Date

May 12, 2024

Last Update Submit

April 20, 2025

Conditions

Keywords

Lidocaine atomized particlesNebulizationAwake tracheal intubationIndividual topicalization technique

Outcome Measures

Primary Outcomes (1)

  • cough score

    Investigators will record cough score during intubation.

    during intubation

Secondary Outcomes (2)

  • reaction and discomfort scores

    during intubation.

  • intraoperative hemodynamic parameters

    endotracheal tube insertion, inflation of the tracheal tube cuff and 1 minute after endotracheal tube insertion

Study Arms (4)

Group A

EXPERIMENTAL

Participants in the A group received 2% lidocaine by A model atomizer.

Other: atomizer

Group B

EXPERIMENTAL

Participants in the B group received 2% lidocaine by B model atomizer.

Other: atomizer

Group C

EXPERIMENTAL

Participants in the C group received 2% lidocaine by C model atomizer.

Other: atomizer

Group D

EXPERIMENTAL

Participants in the D group received 2% lidocaine by D model atomizer.

Other: atomizer

Interventions

Participants received 2% lidocaine by atomizer.

Also known as: a wearable and disposable vibrating mesh nebulizer
Group AGroup BGroup CGroup D

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with distinctly difficult airways:(1) Patients with medical history indicating difficult airways.(2) Patients suffering from severe burn scars.(3) Patients suffering from severe obstructive sleep apnea syndrome.(4)Patients suffering from severe congenital dysplasia.
  • Patients with suspected difficult airway:
  • Patients with risk factors underwent a medical history for evaluation:(1)Patients with ankylosing spondylitis.(2) Patients with rheumatoid arthritis.(3)Patients with degenerative osteoarthritis.(4)Patients with epiglottitis. (5)Patients with acromegaly.(6)Patients with morbid obesity.(7)Patients with subglottic stenosis. (8) Patients with enlarged thyroid or tonsils.(9)Patients with mediastinal mass.(10)Patients with throat tumors.
  • Patients with risk factors underwent a physical examination for evaluation:(1)Patients with BMI \> 26 kg/m2. (2)Patients with Mallampati class 3 or 4. (3)Patients with thyromental distance\<60 mm (corresponding to an average distance of 3 finger breadths).(4)Patients with limited mouth opening with interincisor distance\<30 mm.(5)edentulous patients.(6)When the patient closed his mouth in a natural state, the upper incisor was situated in front of the lower incisor.(7)When the mandible is extended forward, the lower incisors of the patient can not protrude beyond the upper incisors.(8)The patient's jaw exhibits stiffness, with minimal elasticity or presence of a tumor.(9)The patients have a short neck with a thick circumference.(10)The patients are unable to touch their chest wall with their jaw, or extend their neck.(11)The patients's palate shape is either characterized by a high arch or is extremely narrow.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henan Provincial People's Hospital

Zhengzhou, Henan, 450003, China

Location

Related Publications (1)

  • Li C, Sun M, Zhang L, Wang G, Lu J, Xie Z, Zhang J. Nebulization with differently sized 2% lidocaine atomized particles in awake tracheal intubation by video laryngoscopy: a proof-of-concept randomized trial. BMC Anesthesiol. 2025 Jul 1;25(1):321. doi: 10.1186/s12871-025-03178-9.

MeSH Terms

Interventions

Nebulizers and Vaporizers

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Officials

  • Jiaqiang Zhang, PHD

    Henan Provincial People's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2024

First Posted

May 20, 2024

Study Start

September 5, 2024

Primary Completion

January 30, 2025

Study Completion

February 5, 2025

Last Updated

April 22, 2025

Record last verified: 2024-09

Locations